Filter
5192
Filtered Results: 5192
Text search:
severe
infections
Featured
Recommendations
624
New Publications
1243
Language
Document type
No document type
2601
Guidelines
905
Studies & Reports
801
Manuals
252
Fact sheets
211
Strategic & Response Plan
195
Training Material
105
Situation Updates
55
Infographics
19
Resource Platforms
14
Brochures
13
Online Courses
12
Dashboards/Maps
4
Videos
4
App
1
Countries / Regions
India
288
Global
201
Kenya
119
South Africa
114
Sierra Leone
108
Liberia
108
Ethiopia
108
Western and Central Europe
94
Latin America and the Carribbean
88
Uganda
86
Nigeria
84
Africa
82
Nepal
79
Rwanda
71
Malawi
69
Syria
63
Tanzania
63
Bangladesh
62
Myanmar / Burma
55
West and Central Africa
55
Russia
53
Brazil
51
Mozambique
50
Ghana
48
Zambia
48
Middle East and North Africa
48
East and Southern Africa
47
Philippines
44
South–East Asia Region
41
Congo, Democratic Republic of
39
Ukraine
38
Zimbabwe
36
Haiti
36
South Sudan
36
Guinea
32
Namibia
30
Lesotho
29
Yemen
29
Eastern Europe
27
Germany
25
Indonesia
25
Cambodia
24
Senegal
23
Eastern Europe and Central Asia
23
Burkina Faso
21
Asia
20
Western Pacific Region
18
Venezuela
18
Angola
16
USA
14
Eswatini/ Swaziland
14
Colombia
14
Pakistan
13
Cameroon
12
Afghanistan
12
Peru
11
Botswana
11
Vietnam
11
Guinea-Bissau
10
Somalia
10
Sudan
10
Iraq
9
Turkey
9
Central African Republic
9
Madagascar
8
Chile
8
Spain
8
Thailand
7
Albania
7
Saudi Arabia
6
Jordan
6
Lebanon
6
China
6
Italy
6
Tajikistan
6
United Kingdom
6
Mali
5
Ecuador
5
Bolivia
5
Mexico
5
Palestine
5
Moldova
5
Georgia
5
Côte d’Ivoire / Ivory Coast
4
Niger
4
Papua New Guinea
4
Benin
4
Argentina
4
Southern Africa
4
France
4
Portugal
4
Egypt
3
Chad
3
Gambia
3
North Macedonia
3
Greece
3
Sri Lanka
3
Laos
3
Timor Leste/ East Timor
3
Iran
3
Kazakhstan
3
Turkmenistan
3
Morocco
2
Togo
2
Singapore
2
Serbia
2
Burundi
2
Other region
2
Paraguay
2
Fiji
2
Uzbekistan
2
North America
2
Mauritius
2
Malaysia
1
Dominican Republic
1
Austria
1
Switzerland
1
Honduras
1
El Salvador
1
Libya
1
Nicaragua
1
Solomon Islands
1
Bhutan
1
Djibouti
1
Armenia
1
Congo-Brazzaville
1
Canada
1
Qatar
1
Bulgaria
1
Kyrgyzstan
1
Australia
1
Jamaica
1
Denmark
1
Tunisia
1
French Guyana
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2004
Clinical Guidelines
569
Women & Child Health
336
Public Health
232
Key Resources
165
Capacity Building
113
Pharmacy & Technologies
47
Annual Report MEDBOX
2
Toolboxes
COVID-19
972
HIV
315
TB
287
Mental Health
216
Rapid Response
208
Ebola
192
NTDs
175
Caregiver
140
AMR
136
Planetary Health
136
Conflict
112
Disability
104
Refugee
89
NCDs
85
Pharmacy
72
Cholera
55
Natural Hazards
55
Zika
51
Global Health Education
50
Health Financing Toolbox
29
Specific Hazards
27
Polio
22
South Sudan
2
Typhoon
2
Social Ethics
1
The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectab...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-... COVID-19
The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
Community Engagement During Public Health Emergencies Like COVID-19: An Action Framework and Toolkit
This handbook offers a simple framework of action for actors in local government, and in particular, health leaders such as Civil Surgeons (CSs) and Upazila Health and Family Planning Officers (UHFPQOs), to take ownership and leadership to combat COVID-19 at each district and upazila respectively, w...
National HIV curriculum
You can always find the most up to date version of this document at
https://www.hiv.uw.edu/go/co-occurring-conditions/opportunistic-infections-prevention/coreconcept/all
Dengue is a mosquito-borne viral disease that has rapidly spread to all regions of WHO in recent years. Dengue virus is transmitted by female mosquitoes mainly of the species Aedes aegypti and, to a lesser extent, Ae. albopictus. These mosquitoes are also vectors of chikungunya, yellow fever and Zik...
These guidelines provide recommendations for the non-pharmacological aspects of infection prevention and control for acute respiratory diseases (ARD) in health care. Administrative and infection con...
This document aims to encourage countries to develop and implement policies to maintain and strengthen IPC programmes and measures in health care facilities in the context of the current ongoing transmission of the SARS-CoV-2, with recognition that epidemiological trends may vary and the risk of tra...
Diarrhea is one of the world’s leading causes of child illness and death, and rotavirus is the most common cause of severe diarrhea. Yet it can be prevented and treated. There is a vaccine. And while hundreds of thousands of children in India will...
Managing possible serious bacterial infection in young infants when referral is not feasible
recommended
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker. The guideline seeks to provide programmatic guida...
This document was prepared in response to a need to review and potentially update the current recommendations for the antibiotic treatment of both inpatient and outpatient management of severe acute malnutrition (SAM). The current recommendations (T...
Centre de traitement des infections respiratoires aiguës sévères : manuel pratique pour la mise en place et la gestion d’un centre de traitement des IRAS et d’une unité de dépistage des IRAS dans les établissements de soins
Infection prevention and control (IPC) practices are of critical importance in protecting the function of healthcare services at all levels and mitigating the impact on vulnerable populations. Although the management of possible COVID-19 cases is us...
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker. The guideline seeks to provide programmatic guida...
Managing possible serious bacterial infection in young infants 0–59 days old when referral is not feasible
recommended
WHO/UNICEF joint statement
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In thi...
